Back to Results

SINOPHARM GROUP CO LTD ADR (SHTDY)

Sinopharm Group Co. Ltd. is a Hong Kong-listed healthcare group whose ADR trades over the counter in the United States as a depositary receipt. Through its subsidiaries, the company is active in the wholesale and retail distribution of pharmaceutical and healthcare products and medical devices in the People’s Republic of China. Its operations are organized into four segments: Pharmaceutical Distribution, Medical Devices Distribution, Retail Pharmacy, and Other Business. The pharmaceutical distribution business serves hospitals, distributors, pharmacies, and clinics, while also providing logistics and related value-added services. The medical devices unit handles distribution as well as installation and maintenance services. Its retail pharmacy operations include both directly operated and franchised drug stores. The company also participates in laboratory supplies, chemical reagents, pharmaceutical manufacturing, property rental and management, consulting, information technology, import and export activities, and other healthcare-related services. Founded in 2003, Sinopharm Group is headquartered in Shanghai and is a subsidiary of Sinopharm Industrial Investment Co., Ltd.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
OTC-SHTD.Y
$13.45
22.3% Upside
Undervalued
—
—
—
Good
June 24, 2026
September 8, 2026
0.39
3.5%
August 28, 2026
6.7x
0.6x
0.1x
6.893 B
18.053 B
43.5%
40.8%
6.3
28.2%
206.9%
Valuation • Fair Value

SINOPHARM GROUP CO LTD ADR (OTC-SHTD.Y) Fair Value by Valuation Model

Compare the primary fair value estimate for SINOPHARM GROUP CO LTD ADR (OTC-SHTD.Y) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$13.45

Estimated upside of 22.3% versus the current market price.

Fair Value Confidence

High

Confidence level for the primary fair value estimate.

DCF Fair Value

$14.15

Discounted cash flow valuation reference.

Ben Graham Formula Value

$18.54

Classic Ben Graham valuation formula reference.

DDM Fair Value

$16

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

$12.45

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use this section to compare the primary fair value estimate for SINOPHARM GROUP CO LTD ADR (OTC-SHTD.Y) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for SINOPHARM GROUP CO LTD ADR (OTC-SHTD.Y)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

83.252 B

Current operating scale indicator.

Revenue Forecast

87.561 B

Forward revenue estimate.

EBITDA

2.775 B

Current operating profitability reference.

EBITDA Forecast

3.123 B

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review SINOPHARM GROUP CO LTD ADR (OTC-SHTD.Y) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for SINOPHARM GROUP CO LTD ADR (OTC-SHTD.Y)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Good

Positive financial-health read.

Piotroski Score

7

Relatively strong quality score.

Beneish M-Score

-2.59

No elevated caution signal from this screen.

Altman Z-Score

6.3

Relatively strong balance-sheet zone.

FCF / Net Income

206.9%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for SINOPHARM GROUP CO LTD ADR (OTC-SHTD.Y). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for SINOPHARM GROUP CO LTD ADR (OTC-SHTD.Y)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

August 28, 2026

Days to Earnings

38

Dividend Payment Date

September 8, 2026

Ex-Dividend Date

June 24, 2026

Dividend Yield

3.5%

Income yield reference.

Upcoming Dividend

0.39

Upcoming distribution amount.

Payment Type

Cash

Distribution type as reported in the data.

Dividend Currency

USD

Currency used for the distribution.

Payout Ratio

28.2%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for SINOPHARM GROUP CO LTD ADR (OTC-SHTD.Y), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

SINOPHARM GROUP CO LTD ADR (OTC-SHTD.Y) Stock Forecast & Technical Outlook

Review SINOPHARM GROUP CO LTD ADR (OTC-SHTD.Y) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for SINOPHARM GROUP CO LTD ADR (OTC-SHTD.Y) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Sell

The 1-hour technical read for SINOPHARM GROUP CO LTD ADR (OTC-SHTD.Y) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Neutral

The daily technical read for SINOPHARM GROUP CO LTD ADR (OTC-SHTD.Y) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for SINOPHARM GROUP CO LTD ADR (OTC-SHTD.Y) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for SINOPHARM GROUP CO LTD ADR (OTC-SHTD.Y) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for SINOPHARM GROUP CO LTD ADR (OTC-SHTD.Y)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Not available

Analyst recommendation data for SINOPHARM GROUP CO LTD ADR (OTC-SHTD.Y) is not currently available.

Buy 0
Hold 0
Sell 0
FAQ • Fast Investor Answers

SINOPHARM GROUP CO LTD ADR (OTC-SHTD.Y) Stock FAQ

Quick answers about SINOPHARM GROUP CO LTD ADR (OTC-SHTD.Y) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$13.45
Estimated upside 22.3%
Valuation Rating
Undervalued
Estimated upside of 22.3%
Analyst Target
Not available
Data is currently unavailable
Financial Health
Good
Current financial-health read

The current fair value estimate for SINOPHARM GROUP CO LTD ADR (OTC-SHTD.Y) is $13.45. This implies an estimated upside of 22.3% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 22.3% versus the current market price.

An analyst price target for SINOPHARM GROUP CO LTD ADR (OTC-SHTD.Y) is not currently available in the latest data file.

The current financial health read for SINOPHARM GROUP CO LTD ADR (OTC-SHTD.Y) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for SINOPHARM GROUP CO LTD ADR (OTC-SHTD.Y) is August 28, 2026.

Based on the current data, dividend yield is 3.5%, upcoming dividend amount is 0.39, ex-dividend date is June 24, 2026, payment date is September 8, 2026.

The current P/E ratio listed for SINOPHARM GROUP CO LTD ADR (OTC-SHTD.Y) is 6.7x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for SINOPHARM GROUP CO LTD ADR is 6.893 B.

The current enterprise value listed for SINOPHARM GROUP CO LTD ADR is 18.053 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for SINOPHARM GROUP CO LTD ADR is OTC-SHTD.Y, and the stock is listed on OTC Markets.

SINOPHARM GROUP CO LTD ADR (OTC-SHTD.Y) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for SINOPHARM GROUP CO LTD ADR is 43.5%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for SINOPHARM GROUP CO LTD ADR is 40.8%. Free float helps investors understand how much of the share base is available for public trading.

Similar Healthcare Providers & Services Stocks on OTC Markets View more

Fresenius SE & Co KGaA ADR (FSNUY) Fresenius SE & Co KGaA ADR (FSNUY)
Bangkok Dusit Medical Services PCL ADR (BDUUY) Bangkok Dusit Medical Services PCL ADR (BDUUY)
Shanghai Pharmaceuticals Holding Co Ltd ADR (SHPMY) Shanghai Pharmaceuticals Holding Co Ltd ADR (SHPMY)
Sonic Healthcare Ltd ADR (SKHHY) Sonic Healthcare Ltd ADR (SKHHY)
Ramsay Health Care Ltd ADR (RMYHY) Ramsay Health Care Ltd ADR (RMYHY)
Bumrungrad Hospital PCL DRC (BUGDF) Bumrungrad Hospital PCL DRC (BUGDF)
Medipal Holdings Corp ADR (MAHLY) Medipal Holdings Corp ADR (MAHLY)
Extendicare Inc (EXETF) Extendicare Inc (EXETF)
Netcare Ltd ADR (NWKHY) Netcare Ltd ADR (NWKHY)
Ryman Healthcare Ltd ADR (RYHTY) Ryman Healthcare Ltd ADR (RYHTY)
Rhoen Klinikum AG ADR (RKAGY) Rhoen Klinikum AG ADR (RKAGY)
Life Healthcare Group Holdings (LTGHY) Life Healthcare Group Holdings (LTGHY)
Medical Facilities Corporation (MFCSF) Medical Facilities Corporation (MFCSF)
Healwell Al Inc (HWAIF) Healwell Al Inc (HWAIF)
Global Cord Blood Corp (CORBF) Global Cord Blood Corp (CORBF)
Kenilworth Systems C (GAMG) Kenilworth Systems C (GAMG)
Interpace Biosciences Inc (IDXG) Interpace Biosciences Inc (IDXG)
Elite Health Systems Inc (EHSI) Elite Health Systems Inc (EHSI)
Exlites Holdings International Inc (EXHI) Exlites Holdings International Inc (EXHI)
Psychemedics Corporation (PMDI) Psychemedics Corporation (PMDI)
Syra Health Corp (SYRA) Syra Health Corp (SYRA)
Cardiff Lexington Corp (CDIX) Cardiff Lexington Corp (CDIX)
Pacific Health Care Organization Inc (PFHO) Pacific Health Care Organization Inc (PFHO)
BioCorRx Inc (BICX) BioCorRx Inc (BICX)